K-321

· Kowa Research Institute, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for K-321, covering 2024-11-05 to 2024-11-05. Get the full timeline:

Most recent: Clinical Trial Update: Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis [Phase 2]

See pricing